Is cytoreductive surgery and hyperthermic intraperitoneal chemotherapy indicated in hepatobiliary malignancies?

Natasha L LeighDaniel SolomonEric PletcherDaniel M LabowDeepa R MaggeUmut SarpelBenjamin J Golas

Published in: World journal of surgical oncology (2020)

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy may offer a survival benefit in select hepatocellular carcinoma patients with peritoneal carcinomatosis, though has dubious utility in pancreaticobiliary malignancies.

Keyphrases

minimally invasive
coronary artery bypass
locally advanced
surgical site infection
metastatic renal cell carcinoma
coronary artery disease
free survival
atrial fibrillation
chemotherapy induced